CINECA IRIS Institutional Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishLearning disorders' frequency is relatively high in the school population. In last years several drugs have been proposed, in particular nootropics drugs. Fifteen children (ages 8 years and 2 months to 14 years and 3 months) with learning disabilities were enrolled in this study. They were randomly and blindly assigned to receive either placebo or oxiracetam (30 mg/kg/day) for 6 months. At the beginning and end of the study neuropsychological and electrophysiological tests were administered. There were no statistically significant differences between placebo and oxiracetam treatment groups with regard to neuropsychological performances and electrophysiological characteristics. Only a small number of subjects (3 patients of oxiracetam treated group and 1 patient of placebo treated group) had significant improvement of cognitive functions and results of electrophysiological features.
Scheda prodotto non validato
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo
| Titolo: | NOOTROPIC DRUGS AND LEARNING-DISORDERS - A PARALLEL NEUROPSYCHOLOGIC AND ELECTROPHYSIOLOGIC STUDY |
| Autori: | |
| Data di pubblicazione: | 1994 |
| Rivista: | |
| Abstract: | Learning disorders' frequency is relatively high in the school population. In last years several drugs have been proposed, in particular nootropics drugs. Fifteen children (ages 8 years and 2 months to 14 years and 3 months) with learning disabilities were enrolled in this study. They were randomly and blindly assigned to receive either placebo or oxiracetam (30 mg/kg/day) for 6 months. At the beginning and end of the study neuropsychological and electrophysiological tests were administered. There were no statistically significant differences between placebo and oxiracetam treatment groups with regard to neuropsychological performances and electrophysiological characteristics. Only a small number of subjects (3 patients of oxiracetam treated group and 1 patient of placebo treated group) had significant improvement of cognitive functions and results of electrophysiological features. |
| Handle: | http://hdl.handle.net/11567/384137 |
| Appare nelle tipologie: | 01.01 - Articolo su rivista |
File in questo prodotto:
Copyright © 2020